Phathom Pharmaceuticals, Inc.
PHAT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$29,973 | -$75,810 | -$94,316 | -$74,451 |
| Dep. & Amort. | $156 | $172 | $177 | $193 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $9,297 | $8,272 | $5,540 | $6,687 |
| Change in WC | -$1,557 | -$5,951 | -$8,914 | -$9,036 |
| Other Non-Cash | $7,962 | $10,588 | $12,583 | $13,151 |
| Operating Cash Flow | -$14,115 | -$62,729 | -$84,930 | -$63,456 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$27 | -$97 | -$18 | -$5 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$27 | -$97 | -$18 | -$5 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $24,750 |
| Stock Issued | $293 | $80 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$564 | $0 | $0 | $1,296 |
| Financing Cash Flow | -$271 | $80 | $0 | $26,046 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$14,413 | -$62,746 | -$84,948 | -$37,415 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $152,431 | $215,177 | $300,125 | $337,540 |
| End Cash | $138,018 | $152,431 | $215,177 | $300,125 |
| Free Cash Flow | -$14,115 | -$62,729 | -$84,948 | -$63,461 |